I wonder what the FDA would have done with the TEVA/Amphastar applications if Momenta hadn't come along with its application (as well as helping to resolve the heparin contamination)?
Would the FDA have approved one or both of their applications by now? That is, would the FDA have realized that their products were inferior to Lovenox without Momenta's ability to fully characterize Lovenox?
PS: Thanks, Dew, for your coverage/analysis of MNTA! Helped me tremendously in my brokerage account.
Market Data 
Markets 
AI
